An FP7 EU Funded R&D Project

Fujirebio Diagnostics AB is a biotechnology company located in Göteborg, Sweden. The company is the continuation of CanAg Diagnostics AB, which was acquired by Fujirebio Diagnostics Inc, Malvern, PA, US in May 2006. Fujirebio Diagnostics Inc is a wholly owned subsidiary of Fujirebio Inc, Tokyo, Japan. FDAB has through its parent company large experience in market introduction of novel biomarkers for cancer diagnosis.

Fujirebio will provide monoclonal antibodies and support in the identification of antigen biomarkers.
Fujirebio Diagnostics AB, Göteborg, Sweden